Pfizer Increase (Decrease) in Other Operating Assets remained flat by 0.0% to -$322.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 61.9%, from -$845.00M to -$322.25M. Over 4 years (FY 2021 to FY 2025), Increase (Decrease) in Other Operating Assets shows a downward trend with a 5.1% CAGR.
An increase represents a use of cash, while a decrease represents a source of cash from working capital adjustments.
Reflects the net change in miscellaneous operating assets not captured in specific line items like receivables or invent...
Standard working capital line item found in most corporate cash flow statements.
operating_increase_decrease_in_other_operating_assets| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.06B | $4.51B | $663.00M | -$3.38B | -$1.29B |
| YoY Change | — | +326.3% | -85.3% | -609.8% | +61.9% |